Back
Verrica Pharmaceuticals 10K Form
Buy
55
VRCA
Verrica Pharmaceuticals
Last Price:
6.94
Seasonality Move:
-18.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-05 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2020-05-07 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2020-03-13 | 10K | VRCA/Verrica Pharmaceuticals Annual |
| 2019-11-06 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2019-08-07 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2019-05-07 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
Receive VRCA News And Ratings
See the #1 stock for the next 7 days that we like better than VRCA
VRCA Financial Statistics
Sales & Book Value
| Annual Sales: | $5.12M |
|---|---|
| Cash Flow: | $-14.73M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.47 |
| Price / Book: | 14.51 |
Profitability
| EPS (TTM): | -1.47000 |
|---|---|
| Net Income (TTM): | $-67M |
| Gross Margin: | $4.38M |
| Return on Equity: | -150.66% |
| Return on Assets: | -94.54% |
Verrica Pharmaceuticals Earnings Forecast
Key Verrica Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 3 years for VRCA is 85.44%.
- The Selling, General & Administrative Expenses for VRCA have been equal to 923.20% of Gross Profit Margin.
- The Research & Development expenses have been 396.08% of Revenue.
- The Interest Expense is -5.91% of Operating Income.
- The Net Earning history of VRCA is -1,307.47% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 3 years.
Verrica Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VRCA |
| CUSIP: | 92511W |
| Website: | verrica.com |
Debt
| Debt-to-Equity Ratio: | 2.17 |
|---|---|
| Current Ratio: | 4.55 |
| Quick Ratio: | 4.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VRCA Technical Analysis vs Fundamental Analysis
Buy
55
Verrica Pharmaceuticals (VRCA)
is a Buy
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a Buy
The current Verrica Pharmaceuticals [VRCA] share price is $6.76. The Score for VRCA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.